On February 10, 2026, GSK plc reported that executives, including Lynn Baxter and Julie Brown, each acquired 12 ordinary shares at £21.7918 through the Share Reward Plan. Additionally, 10,000 American Depositary Shares were sold at $59.1802 by a company member on February 9, 2026.